Cormorant Asset Management, LP Rocket Pharmaceuticals, Inc. Transaction History

Cormorant Asset Management, LP

$1.43 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $3.92 Million - $4.61 Million	-150,000 Reduced 33.33%	300,000 $8.08 Million
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $6.31 Million - $10.1 Million	-418,550 Reduced 48.19%	450,000 $9.22 Million
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $2.15 Million - $3.6 Million	-100,000 Reduced 10.32%	868,550 $19 Million
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $15.8 Million - $18.9 Million	-400,000 Reduced 29.23%	968,550 $42.9 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $2.05 Million - $2.86 Million	-100,000 Reduced 6.81%	1,368,550 $31.3 Million
Q2 2020 Aug 14, 2020	SELL	$13.32 - $22.61 $1.33 Million - $2.26 Million	-100,000 Reduced 6.38%	1,468,550 $30.7 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $2.61 Million - $6.75 Million	-268,719 Reduced 14.63%	1,568,550 $21.9 Million
Q4 2019 Feb 14, 2020	SELL	$11.07 - $24.23 $3.17 Million - $6.94 Million	-286,491 Reduced 13.49%	1,837,269 $41.8 Million
Q3 2019 Nov 14, 2019	BUY	$10.85 - $14.78 $533,440 - $726,658	49,165 Added 2.37%	2,123,760 $24.7 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $5.62 Million - $7.42 Million	374,595 Added 22.04%	2,074,595 $31.1 Million
Q1 2019 May 15, 2019	SELL	$13.45 - $19.01 $3.3 Million - $4.67 Million	-245,659 Reduced 12.63%	1,700,000 $29.8 Million
Q4 2018 Feb 14, 2019	BUY	$11.21 - $23.53 $4.99 Million - $10.5 Million	445,000 Added 29.65%	1,945,659 $28.8 Million
Q3 2018 Nov 14, 2018	SELL	$18.5 - $25.49 $355,773 - $490,198	-19,231 Reduced 1.27%	1,500,659 $36.9 Million
Q2 2018 Aug 14, 2018	SELL	$14.58 - $23.0 $14 - $23	-1 Reduced -0.0%	1,519,890 $29.8 Million
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $17.8 Million - $29.2 Million	1,519,891 New	1,519,891 $28.5 Million

Others Institutions Holding RCKT

# of Institutions

210

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$184 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$117 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$64.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$57.6 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$46.8 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $788M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account